Sumitomo Pharma has a total of 103 patents globally, out of which 29 have been granted. Of these 103 patents, more than 68% patents are active. The United States of America is where Sumitomo Pharma has filed the maximum number of patents, followed by Canada and Mexico. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Sumitomo Pharma.
Sumitomo Pharma also known as Sumitomo Dainippon Pharma was founded in 2005. Sumitomo Pharma is a company that mainly sells specialty and generic drugs, with most of its sales coming from North America and Japan. Their main focus is on pharmaceutical products, especially in areas like cardiovascular/diabetes, psychiatry & neurology, and specialty fields. They also see mergers and acquisitions as a way to grow by improving their research, development, manufacturing, and marketing abilities.
Do read about some of the most popular patents of Sumitomo Pharma which have been covered by us in this article and also you can find Sumitomo Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sumitomo Pharma patent portfolio.
How many patents does Sumitomo Pharma have?
Sumitomo Pharma has a total of 103 patents globally. These patents belong to 44 unique patent families. Out of 103 patents, 71 patents are active.
How Many Patents did Sumitomo Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Sumitomo Pharma Applications Filed | Sumitomo Pharma Patents Granted |
| 2022 | 5 | 4 |
| 2021 | 10 | 6 |
| 2020 | 17 | 6 |
| 2019 | 10 | 1 |
| 2018 | 12 | 1 |
| 2017 | 8 | 6 |
| 2016 | 13 | – |
| 2015 | 4 | 1 |
| 2014 | 5 | 1 |
| 2013 | 1 | – |
| 2012 | 2 | – |
How many Sumitomo Pharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sumitomo Pharma File in Different Countries?
Countries in which Sumitomo Pharma Filed Patents
| Country | Patents |
| United States of America | 23 |
| Canada | 22 |
| Mexico | 13 |
| Hong Kong (S.A.R.) | 13 |
| Israel | 5 |
| Europe (EPO) | 4 |
| Singapore | 3 |
| Austria | 2 |
| New Zealand | 2 |
| Philippines | 1 |
| Spain | 1 |
| Indonesia | 1 |
| Italy | 1 |
| Malaysia | 1 |
Where are Research Centers of Sumitomo Pharma Patents Located?
10 Best Sumitomo Pharma Patents
US20120058997A1 is the most popular patent in the Sumitomo Pharma portfolio. It has received 30 citations so far from companies like Lexicon Pharmaceuticals, Arisan Therapeutics, Califia Bio.
Below is the list of 10 most cited patents of Sumitomo Pharma:
| Publication Number | Citation Count |
| US20120058997A1 | 30 |
| US8877803B2 | 27 |
| US7998966B2 | 27 |
| US20110269772A1 | 19 |
| US20080214558A1 | 11 |
| US9732055B2 | 7 |
| US9745278B2 | 6 |
| US9834532B2 | 4 |
| US9730909B2 | 4 |
| CA2959951A1 | 4 |
What are Sumitomo Pharma key innovation segments?
What Technologies are Covered by Sumitomo Pharma?
The chart below distributes patents filed by Sumitomo Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Sumitomo Pharma thinks it’s important to protect particular technology inventions.
R&D Focus: How has Sumitomo Pharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!